Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
CDRH’s Shuren Calls For ‘Reset’ Of FDA Medtech Initiatives
Programs disrupted by COVID-19 would be restarted in 2021 to guide developers on clinical decision support software, produce safe OTC hearing aids
Dec 07 2020
•
By
Sue Darcey
More from Regulation
More from Policy & Regulation